Introduction of Validation and Qualification
Introduction of Validation and Qualification
Qualification
Presented by Group 7:
Muhamad Bima Muria (14344143)
Ririn
(14344)
Ellen
(14344)
Sherly
(14344)
Apothecary Profession Program of ISTN Jakarta
What is Validation?
Validation is establishing of documented evidence
which provides a high degree of assurance that a
planned process will consistently perform
according to the intended specified outcomes
(WHO, 1997).
Validation is an essential part of GMP, and an element of
QA . The term of validation is normally used for processes
Cont
Manufacturers should plan validation to ensure:
- regulatory compliance and
- product quality, safety and consistency
Need for confidence that the product will consistently meet
predetermined specifications and attributes.
An quantitative approach is needed to prove quality,
functionality, and performance of a pharmaceutical
manufacturing process.
Protocol contents:
The processes and/or parameters
Sampling, testing and monitoring requirements
Predetermined acceptance criteria for drawing conclusions
Validation protocol should be established to specify and define the validation activity
that will be performed. It reviewed and approved by the head of Quality Assurance
Process Validation
Process validation is defined as the collection and evaluation of
data, from the process design stage throughout production, which
establishes scientific evidence that a process is capable of
consistently delivering quality products.
Operation
Measure humidity with
humidity meter
Weigh granulate - balance
XVI Blend 2
with 3/5
granulate
mixer (speed 1, 30
seconds)
XVIII
Weigh granulate
IQ/OQ/PQ requirements
IQ/OQ
calibration
IQ/OQ
calibration
I Q/OQ/PQ
Cleaning
validation
Critical
control
point
instrument
operation,
cleaning, care
and maintenance
Critical
control
point
Decision as to whether to
compress or not based on
expected yield and actual yield
Training
records for
technician
Prospective Validation
Prospective validation should be performed and completed
before the pharmaceutical product will be sale and
distributed. A minimum of three batches of product is
required.
Prospective validation should include:
Short description of the process
Summary of the critical processing steps to be investigated
List of the equipments/ facilities to be used (completed with
IQ,OQ & PQ document and its calibration status)
Finished product specification for release
List of analytical method
Prospective Validation
Proposed in-process controls with the acceptance criteria
Additional testing to be carried out, with acceptance criteria
Sampling plan (location and frequency)
Method for recording and evaluating method
Functions and responsibilities
Proposed and timetable
Batch size made for process validation (Prospective, Concurrent
& Retrospective) should be the same as the industrial scale batch.
Concurrent Validation
In exceptional circumstance it may be acceptable not to
complete a validation program before routine production
starts.
It can be performed during routine operation/production where
the product had been sale.
For example: when a process is being transferred to a third
party contract manufacturer/assembler.
Documentation requirements same as specified for
prospective validation
The completed protocols and reports should be reviewed and
approved before product is released for sale or supply
Retrospective Validation
Retrospective validation is only acceptable for well established
processes and will be inappropriate where there have been
recent changes in the composition of the product, operating
procedures or equipment.
Source of data should include:
Batch processing an packaging records
Process control chart
Maintenance log book
Records of personnel change
Process capability
Finished product data
Stability result
Retrospective Validation
For Retrospective validation, generally data from ten (10)
to thirty (30) consecutive batches should be examines
and to assess process consistency.
The steps involved in this type of validation still require
the preparation of a protocol, the reporting of the results
of the data review, leading to a conclusion and
recommendation
Cleaning Validation
Cleaning validation should be performed in order to confirm
the effectiveness of a cleaning procedure.
The objectives of Cleaning Validation include prevention of
possible contamination and cross-contamination.
Contamination by a variety of substances:
Contaminants {e.g. microbes, previous products (both API and
excipient residues), residues of cleaning agents, airborne
materials (e.g. dust and particulate matter), lubricants and
ancillary material, such as disinfectants}.
Also decomposition residues from product or detergents
Cleaning Validation
The aspect to be examined:
Visual inspection of the equipment / machinery cleanliness
Determination of residues of active ingredient (along with
degradation when necessary) and cleaning solutions
Examination of microbiological contamination
Inspection last rinse solution for parameters: TOC, pH and
conductivity, to ensure that no residual cleaning materials left
behind.
Validated analytical methods having sensitivity to detect residues
or contaminants should be used.
Cleaning of contact surfaces (machine or equipment) to be
validated, with consideration to non-contact parts. Critical areas
should be identified.
Cleaning Validation
The cleaning validation protocol should include:
Objectives and responsible of personnel
Description of the equipment or machine including model, serial
number, etc.
Time intervals and cleaning procedures;
Equipment used for routine monitoring (e.g. conductivity meters,
pH meters and total organic carbon analyzer);
Number of cleaning cycles; sampling procedures (e.g. direct
sampling, rinse sampling, in process monitoring and sampling
location).
Data on recovery studies (efficiency of the recovery of the
sampling technique should be established);
Analytical methods
Acceptance criteria
Cleaning Validation
Two methods of sampling:
Direct surface sampling (swab)
Rinse samples
Note: combination of the two - most desirable
The three most commonly used criteria are:
Visually clean No residue visible on equipment after cleaning.
Spiking studies to determine the concentration at which most
active ingredients are visible. (May not be suitable for high
potency, low-dosage drugs.)
No more than 10 ppm of one product will appear in another
product (basis for heavy metals in starting materials).
No more than 0.1% of the normal therapeutic dose of one
product will appear in the maximum daily dose of a subsequent
product.
Peak A
LOD
Baseline
noise